Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.80% | 1.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.80% | 1.07% | |||
| Cost of Revenue | 0.98% | 1.79% | |||
| Gross Profit | 5.77% | -0.07% | |||
| SG&A Expenses | 6.02% | 1.49% | |||
| Depreciation & Amortization | 1.50% | 5.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.68% | 1.77% | |||
| Operating Income | 6.30% | -15.99% | |||
| Income Before Tax | 830.47% | -146.45% | |||
| Income Tax Expenses | 225.21% | -34.61% | |||
| Earnings from Continuing Operations | 526.31% | -191.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 526.31% | -191.59% | |||
| EBIT | 6.30% | -15.99% | |||
| EBITDA | -17.95% | -8.35% | |||
| EPS Basic | 529.17% | -192.31% | |||
| Normalized Basic EPS | 4,300.00% | -107.41% | |||
| EPS Diluted | 516.67% | -192.31% | |||
| Normalized Diluted EPS | 4,300.00% | -107.41% | |||
| Average Basic Shares Outstanding | 0.17% | -1.51% | |||
| Average Diluted Shares Outstanding | -1.28% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||